Sloan Leslie 4
4 · Aeglea BioTherapeutics, Inc. · Filed Feb 19, 2021
Insider Transaction Report
Form 4
Sloan Leslie
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-02-17+160,000→ 160,000 totalExercise: $7.35Exp: 2031-02-16→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 17, 2021, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.